Cover Image
市場調查報告書

住宅塵蟎過敏:全球臨床實驗檢討

House Dust Mite Allergy Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318337
出版日期 內容資訊 英文 73 Pages
訂單完成後即時交付
價格
Back to Top
住宅塵蟎過敏:全球臨床實驗檢討 House Dust Mite Allergy Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 73 Pages
簡介

住宅塵蟎過敏,塵蟎產生的引發過敏物質造成的過敏反應。

本報告提供住宅塵蟎過敏的治療藥相關臨床實驗調查分析,提供您臨床實驗數及受驗人數,各階段、及Phase狀況,有潛力的企業,正在開發的治療藥資訊,臨床實驗簡介等相關的系統性資訊。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中南美的主要國家

G7各國的臨床實驗:免疫系臨床實驗上住宅塵蟎過敏所佔的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:各階段

E7各國的臨床實驗:免疫系臨床實驗上住宅塵蟎過敏所佔的比例

E7各國的臨床實驗:Phase別

E7各國的臨床實驗:各階段

各方面的臨床實驗

各階段臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對像

贊助商類別臨床實驗

有潛力的贊助商

  • 住宅塵蟎過敏的治療藥臨床實驗的主要參與企業

有前途藥物

臨床實驗簡介

  • 主要企業臨床實驗概要
    • ALK-Abello A/S
    • Stallergenes S.A.
    • Merck & Co., Inc.
    • Circassia Holdings Ltd.
    • Laboratorios LETI S.L.
    • 日本煙草產業
    • Cytos Biotechnology AG (暫停中)
    • Merck KGaA
    • Lofarma S.p.A.
    • Anergis SA
  • 主要大學·研究機關·醫院臨床實驗概要
    • Medical University of Lodz
    • Johann Wolfgang Goethe University Hospitals
    • Universitaire Ziekenhuizen Leuven
    • Academic Medical Center
    • Ankara University
    • Aalborg University
    • University of South Florida
    • Medical University of Silesia
    • Bayside Health
    • Medical University of Vienna

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2382CTIDB

GlobalData's clinical trial report, "House Dust Mite Allergy Global Clinical Trials Review, H2, 2014" provides data on the House Dust Mite Allergy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on House Dust Mite Allergy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating House Dust Mite Allergy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • House Dust Mite Allergy
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of House Dust Mite Allergy to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of House Dust Mite Allergy to Immunology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of House Dust Mite Allergy
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in House Dust Mite Allergy Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • ALK-Abello A/S
      • Clinical Trial Overview of ALK-Abello A/S
      • Stallergenes S.A.
      • Clinical Trial Overview of Stallergenes S.A.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Circassia Holdings Ltd.
      • Clinical Trial Overview of Circassia Holdings Ltd.
      • Laboratorios LETI S.L.
      • Clinical Trial Overview of Laboratorios LETI S.L.
      • Japan Tobacco Inc.
      • Clinical Trial Overview of Japan Tobacco Inc.
      • Cytos Biotechnology AG (Inactive)
      • Clinical Trial Overview of Cytos Biotechnology AG (Inactive)
      • Merck KGaA
      • Clinical Trial Overview of Merck KGaA
      • Lofarma S.p.A.
      • Clinical Trial Overview of Lofarma S.p.A.
      • Anergis SA
      • Clinical Trial Overview of Anergis SA
    • Clinical Trial Overview of Top Institutes / Government
      • Medical University of Lodz
      • Clinical Trial Overview of Medical University of Lodz
      • Johann Wolfgang Goethe University Hospitals
      • Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals
      • Universitaire Ziekenhuizen Leuven
      • Clinical Trial Overview of Universitaire Ziekenhuizen Leuven
      • Academic Medical Center
      • Clinical Trial Overview of Academic Medical Center
      • Ankara University
      • Clinical Trial Overview of Ankara University
      • Aalborg University
      • Clinical Trial Overview of Aalborg University
      • University of South Florida
      • Clinical Trial Overview of University of South Florida
      • Medical University of Silesia
      • Clinical Trial Overview of Medical University of Silesia
      • Bayside Health
      • Clinical Trial Overview of Bayside Health
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Region, 2014*
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of House Dust Mite Allergy to Immunology Clinical Trials, G7 Countries (%), 2014*
  • House Dust Mite Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • House Dust Mite Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of House Dust Mite Allergy to Immunology Clinical Trials, E7 Countries (%), 2014*
  • House Dust Mite Allergy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • House Dust Mite Allergy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Phase, 2014*
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • House Dust Mite Allergy Therapeutics, Global, Suspended Clinical Trials, 2014*
  • House Dust Mite Allergy Therapeutics, Global, Terminated Clinical Trials, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • House Dust Mite Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by ALK-Abello A/S, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Stallergenes S.A., 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Circassia Holdings Ltd., 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorios LETI S.L., 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Japan Tobacco Inc., 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytos Biotechnology AG (Inactive), 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck KGaA, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Lofarma S.p.A., 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Anergis SA, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Lodz, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitaire Ziekenhuizen Leuven, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ankara University, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Aalborg University, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Silesia, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayside Health, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2014*

List of Figures

  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of House Dust Mite Allergy to Immunology Clinical Trials, G7 Countries (%), 2014*
  • House Dust Mite Allergy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • House Dust Mite Allergy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of House Dust Mite Allergy to Immunology Clinical Trials, E7 Countries (%), 2014*
  • House Dust Mite Allergy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • House Dust Mite Allergy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • House Dust Mite Allergy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • House Dust Mite Allergy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • House Dust Mite Allergy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top